NCT00020332View on ClinicalTrials.gov

Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Study Completion Date

March 31, 2003

Conditions
Breast Cancer
Interventions
DRUG

alvocidib

DRUG

docetaxel

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020332 - Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter